SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Submission of Matters to a Vote of Security Holders
Item5.07. Submission of Matters to a Vote of Security Holders.
On May 19, 2017, at the 2017 Annual Meeting of Stockholders (the
Annual Meeting) of SenesTech, Inc. (the Company), the Companys
stockholders approved the two proposals listed below. The final
results for the votes regarding each proposal are set forth
below. The proposals are described in detail in the Companys
definitive proxy statement for the Annual Meeting (the Proxy),
filed with the Securities and Exchange Commission on April20,
2017.
| 1. |
To elect the following individuals to the board of directors: Julia Williams, M.D. and Marc Dumont as ClassI directors, each to serve for a three-year term until the annual general meeting of stockholders to be held in 2020 and until her or his successor is duly elected and qualified: |
| Name | Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||||||
| Julia Williams, M.D. | 5,153,138 | 655,847 | 29,958 | 1,168,335 | ||||||||||||
| Marc Dumont | 5,252,623 | 475,259 | 111,061 | 1,168,335 | ||||||||||||
| 2. |
To ratify the appointment of MK CPAS, PLLC as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017: |
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||
| 6,823,566 | 145,803 | 37,909 | ||||||||||||
About SenesTech, Inc. (NASDAQ:SNES)
SenesTech, Inc. is a platform biotechnology company. The Company is engaged in developing a technology for managing animal pest populations through fertility control. Its approach is designed to manage food security and manage infrastructure damage, disease outbreaks, environmental contamination and other costs associated with rodent infestations. Its fertility control product candidate, ContraPest, will be marketed for use in controlling rat populations. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. The Company applies its technology to manage rats in urban and agricultural settings. It has a pipeline of fertility control and animal health products, which include ContraPest, Plant-based fertility control, Feral animal fertility control, Boar taint, and Non-Surgical Spay and Neutering. SenesTech, Inc. (NASDAQ:SNES) Recent Trading Information
SenesTech, Inc. (NASDAQ:SNES) closed its last trading session up +0.09 at 7.05 with 5,174 shares trading hands.
